Image Place holder

Mintallah Haider, MD

Specialty: Hematology/Oncology
Program: Satellite and Community Oncology

Call 1-888-MOFFITT

Call 1-888-MOFFITT


Cancer Focus: Anal Cancer, Appendiceal (Appendix) Cancer, Cholangiocarcinoma (Bile Duct Cancer), Colon Cancer, Colorectal Cancer , Esophageal Cancer , Gallbladder Cancer , Gastrointestinal Carcinoid Tumor , Liver Cancer , Pancreatic Cancer , Rectal Cancer , Stomach (Gastric) Cancer

Dr. Haider is an Assistant Member of the Moffitt Medical Group faculty based at Tampa General Hospital (TGH). Dr. Haider received her Bachelor of Science and Medical Degree at the University of Florida in Gainesville, FL. She completed an internship followed by residency in Internal Medicine at the University of Southern California in Los Angeles, CA. She completed a Hematology and Medical Oncology Fellowship at the University of South Florida and Moffitt Cancer Center in Tampa, FL. Her clinical practice at TGH is comprehensive and includes benign and malignant hematology as well as medical oncology. Dr. Haider’s academic interests encompass clinical research focused on the treatments of gastrointestinal and hepatobiliary malignancies. She is a Clinical Educator in the Department of Satellite Oncology, where she also participates in the education of medical students, residents and fellows.

Education & Training

Board Certification:

  • Internal Medicine


  • University of South Florida - Hematology and Medical Oncology


  • University of Southern California - Internal Medicine

Medical School:

  • University of Florida College of Medicine(MD, - MD)
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.


  • Zhang Q, Haider M, Al Ali NH, Lancet JE, Epling-Burnette PK, List AF, Padron E, Komrokji RS. SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes. Clin Lymphoma Myeloma Leuk. 2020 Jan. Pubmedid: 32179032.
  • Al-Toubah T, Strosberg J, Halfdanarson T, Oleinikov K, Gross DJ, Haider M, Sonbol MB, Almquist D, Grozinsky-Glasberg S. Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia. Chest. 2020 Feb. Pubmedid: 32059961.
  • Haider M, Al-Toubah T, El-Haddad G, Strosberg J. Molecular imaging and radionuclide therapy of neuroendocrine tumors. Curr Opin Endocrinol Diabetes Obes. 2019 Nov.27(1):16-21. Pubmedid: 31789833.
  • Haider M, Duncavage EJ, Afaneh KF, Bejar R, List AF. New Insight Into the Biology, Risk Stratification, and Targeted Treatment of Myelodysplastic Syndromes. Am Soc Clin Oncol Educ Book. 2017 Dec;37:480-494. Pubmedid: 28561687.
  • Haider M, Al Ali N, Padron E, Epling-Burnette P, Lancet J, List A, Komrokji R. Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic Syndrome. Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S44-S48. Pubmedid: 27521323.
  • Aldoss I, Ji L, Haider M, Pullarkat V. The combination of fludarabine, cytarabine and etoposide is an active and well-tolerated regimen in relapsed/refractory acute myeloid leukemia. Acta Haematol. 2014 Jul;131(4):202-207. Pubmedid: 24296475.
  • Hubsher G, Haider M, Okun MS. Amantadine: the journey from fighting flu to treating Parkinson disease. Neurology. 2012 Apr;78(14):1096-1099. Pubmedid: 22474298.
  • Tzachanis D, Haider M, Papazisis G. A Case of Subacute Encephalopathy Developing After Treatment With Clofarabine and Methotrexate That Resolved With Corticosteroids. Am J Ther. 23(3):e937-e940. Pubmedid: 24987945.